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Objective: To evaluate the serum leptin levels in cannabis smokers.
Methods: This was a cross-sectional population-based study of participants between the ages of
18 and 35 years. The data were collected through a self-administered questionnaire covering socio-
demographic data and the use of psychoactive substances. Leptin levels were measured using a
commercial ELISA kit.
Results: Of the 911 participants, 6.7% were identified as cannabis smokers and had significantly
lower leptin levels (p = 0.008). When stratified by gender, there was a significant decrease in leptin
levels among male smokers (p = 0.039).
Conclusion: Cannabis smoking was linked to leptin levels in men, suggesting that the response to
biological signals may be different between men and women.
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Introduction
Cannabis is the world’s most widely used illicit drug,
with high prevalence rates in Latin America.1 It has been
documented in the literature that cannabis stimulates the
appetite, which appears to be linked to D-9-tetrahidro-
canabinol (THC) and cannabidiol (CBD), its main active
substance, through the activation of CB1 receptor (CB1R).2,3
CB1R is widely expressed in the hypothalamus, which is
the key region involved in the regulation of appetite and
includes appetite hormones, such as leptin.4 Leptin is a
hormone released primarily from adipocytes. It reaches
the brain through the bloodstream, binding to specific
receptors. This hormone is considered one of the major
regulators of food intake and metabolic rate, since it is
associated with energy balance. It acts on the hypothalamus
and activates the anorexigenic mechanisms, regulating food
intake.5
Previous studies have shown that there are neurons
sensitive to leptin, including endocannabinoids. CB1R is
blocked by the THC and CBD inhaled from cannabis smoke.
CB1R, which also controls leptin, causes it not to activate,
since the cannabinoid system is under the negative con-
trol of leptin.4,6 However, contradictory results have been
observed about the interaction between cannabis and
appetite hormones. Wagner et al. found that oral admini-
stration of a CB1R antagonist reduced plasma leptin levels
in obese individuals. A study conducted by Di Marzo et al.
revealed that a single intravenous leptin injection in rats
decreased the hypothalamic levels of the endocannabinoids,
anandamide and 2-arachidonyl-glycerol (2-AG) in the
hypothalamus.2,7 However, Riggs et al. found significant
changes in leptin levels after cannabis smoking, but not
in placebo.4
Other studies, moreover, have suggested that gender
impacts the effects of cannabis use. Men consume cannabis
in greater amounts and at higher rates than women.1
On the other hand, Monteleone et al. demonstrated an
inverse relationship between endogenous cannabinoid
and circulating leptin in women.8 To the best of our
knowledge, no prior studies have examined the effects
of cannabis use on leptin in population-based samples.
Thus, the aim of this present study was to evaluate the
serum leptin levels of cannabis users from a population-
based sample between the ages of 18 and 35 years.
Methods
This was a cross-sectional study nested in a population-
based study of 18- to 35-year-old residents of Pelotas (Brazil).
Sample selection was performed by multistage clusters,
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considering the census division of the city (Pelotas) in
2010, which includes a population of 97,000 individuals in
the specified age range within its 495 sectors (Instituto
Brasileiro de Geografia e Estatı´stica [IBGE]; http://www.
ibge.gov.br). In order to guarantee a wide and represen-
tative sample, 83 census-based sectors were system-
atically and randomly selected with a skip of six sectors.
Home selection in the designated sectors was performed
according to a systematic sampling procedure: the first
selected house was at the corner pre-established by the
IBGE as the beginning of the sector, with the next four
houses skipped; thus, every fifth residence was selected.
After initial contact and presentation of the study, residents
of the specified age range were invited to participate and
signed the informed consent form. Individuals unable
to understand and/or respond to the instruments due
to physical or cognitive issues were excluded from the
study. This study was approved by the research ethics
committee of the Universidade Cato´lica de Pelotas (UCPel)
(protocol no. 15/2010).
Socioeconomic evaluation was carried out using
the National Economic Indicator (Indicador Econoˆmico
Nacional – IEN).9 Sociodemographic data, which included
tobacco and/or psychoactive substance use (cocaine,
crack, and Cannabis sativa), were collected through
a self-administered questionnaire. The CAGE question-
naire was used to evaluate alcohol use problems.10
Individuals diagnosed with mood disorder according to
the Mini International Neuropsychiatric Interview (MINI)
and those who reported using crack and/or cocaine were
excluded from the present study.11 A blood sample was
taken between 8:00 a.m. and 11:00 a.m. The serum leptin
levels were measured using a commercially available
immunoassay kit (DuoSet, R&D Systems, Minneapolis,
MN, USA).
The statistical analysis was conducted using GraphPad
Prism 6.0 and SPSS version 21.0 for Windows. The chi-
square test was used for the statistical inference analysis
to describe the total sample and to determine the asso-
ciation between Cannabis sativa users and the socio-
demographic characteristics. The serum leptin levels
had a non-Gaussian distribution. The nonparametric tests
(Mann-Whitney, the Kruskal-Wallis and the Spearman’s
correlation) were used to compare data. Serum leptin
levels were presented as median and interquartile range
(IQR). A linear regression analysis was applied to con-
trol for possible confounding factors, with p p 0.2 in the
bivariate analysis. Results with po 0.05 were considered
statistically significant.
Results
Of the 911 analyzed subjects, 6.7% were identified as
cannabis smokers, and 72.1% were men. Table 1 shows
the sociodemographic and the clinical characteristics of
the sample according to the Cannabis sativa smokers and
the serum leptin levels. Cannabis smokers had a lower
BMI (24.6764.26 kg/m2) and waist circumference (81.996
12.18 cm) than nonsmokers (BMI: 26.1365.49 kg/m2; p =
0.041; waist circumference: 86.17613.03 cm; p = 0.020).
When stratified by gender, the mean BMI (p = 0.037) and
waist circumference (pp 0.001) of male cannabis smokers
remained significantly lower than male nonsmokers. No
difference was found between female cannabis smokers
and nonsmokers regarding BMI and waist circumference.
Serum leptin levels correlated positively with BMI in the
total sample (r = 0.268; pp 0.001) in men (r = 0.533; pp
0.001) and women (r = 0.166; pp 0.001). Moreover, they
correlated with waist circumference in the total sample
(r = 0.106; p = 0.024) in men (r = 0.270; p p 0.001) and
women (r = 0.160; p = 0.010) (data not shown). Cannabis
smokers had significantly decreased serum leptin levels
(p = 0.008). When stratified by gender, however, there
was a significant difference only among men (p = 0.039)
(Figure 1).
A linear regression was carried out to check the sample’s
statistical power. No statistically significant differences
were found in women (p = 0.505; b = -0.031; 95% con-
fidence interval [95%CI] -0.430 to 0.168). Statistically
significant differences were found in men (p = 0.039; b =
-0.155; 95%CI -0.382 to -0.090). To check the influence of
possible confounding factors, we performed an adjusted
analysis for BMI, waist circumference and alcohol use,
and the results remained significant for the total sample
(B = -0.324; p p 0.001), women (B = -0.041; p = 0.380),
and men (B = -0.185; p = 0.049) (data not shown).
Discussion
The present study evaluated serum leptin levels in young
cannabis smokers. Cannabis is the world’s most widely
used illicit substance, especially among young males.1
Users of other illicit drugs, such as cocaine and crack,
were excluded from the present study, since their use can
modulate certain hormones, including leptin.12
Commonly known effects of cannabinoid consumption
are increased food cravings and intake. Kirkham system-
atically reviewed the ‘‘wanting’’ and ‘‘liking’’ aspects in
relation to endocannabinoids and concluded that they
may be essential for reward anticipation and the initiation
of eating and that endocannabinoid activity contributes to
the pleasure associated with food. However, there is an
urgent need to define the psychological consequences of
cannabis smoking in human studies,13 and the influence
of cannabis smoking on appetite hormones has been little
studied.
In our study, we found lower leptin levels in cannabis
smokers than in nonsmokers. Leptin is an important appetite
hormone and is mainly produced from adipocytes, which
modulate central-peripheral communication to maintain
energy balance via hypothalamic receptors.4,5 Previous
studies have suggested that leptin interferes in the of
endogenous cannabinoids levels, which are mediated
by CB1R downregulation.2 However, few studies have
investigated the association between leptin levels and
cannabis smoking. Muniyappa et al. observed no differ-
ence in serum leptin levels between smokers and a
control group,3 while Riggs et al. showed significantly
increased leptin levels in cannabis smokers.4 Previous
studies have described low leptin levels with increased
appetite,2,4 and that cannabis smokers had a 20% higher
calorie intake than nonsmokers.3,14 However, these studies
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did not evaluate the differences between genders. We
believe that the low leptin levels of cannabis smokers may
be associated with the exogenous stimulation of canna-
binoids that, together with the production of endogenous
cannabinoids, can lead to a decrease in leptin levels,
since they are negatively regulated. Moreover, our results
suggest that the mechanisms involving leptin and endo-
cannabinoids may be different between genders.
Regarding the anthropometric variables, the literature
reports that the abdominal obesity rate and mean BMI are
lower in cannabis smokers than nonsmokers, which cor-
roborates our findings. Moreover, we also found that the
abdominal obesity rate and mean BMI, as well as leptin
levels, are lower in male cannabis smokers. Le Strat et al.
found that obesity was significantly lower in cannabis
users than in nonusers (16.1% vs. 22.0%).15 The same
research group has proposed a seemingly paradoxical
hypothesis that THC may produce weight loss and may
be a useful for treating obesity and its complications. This
led to the development of a therapeutic approach using
Figure 1 A) Serum leptin levels in the total sample. Serum leptin levels were significantly lower between cannabis smokers
(3.01 [0.79-12.19] ng/mL) than nonsmokers (9.68 [3.35-25.81] ng/mL; p = 0.008). B) Serum leptin levels in women. No dif-
ference was found between cannabis smokers (11.92 [5.25-45.87] ng/mL) and nonsmokers (13.90 [5.55-48.29] ng/mL;
p = 0.332). C) Serum leptin levels in men. Serum leptin levels were lower in cannabis smokers (1.74 [0.64-8.28] ng/mL) than
nonsmokers (3.74 [1.59-12.04] ng/mL; p = 0.039). Values are presented as box-plots with median and interquartile range.
* p p 0.05 is considered statistically significant.
Table 1 Sociodemographic and clinical characteristics of the sample according to Cannabis sativa smokers and serum leptin
levels
Characteristics
Sample
distribution
Cannabis
sativa
smokers p-value
Leptin levels in
total sample p-value
Leptin levels in
Cannabis sativa
smokers p-value
Gender*w p 0.001 p 0.001 0.006
Female 515 (56.5) 17 (27.9) 13.64 (5.55-47.53) 11.91 (5.09-35.84)
Male 396 (43.5) 44 (72.1) 3.55 (1.50-11.53) 1.93 (0.79-26.45)
Ethnicity*w 0.561 0.533 0.297
Caucasian 630 (75.4) 44 (72.1) 9.71 (3.41-27.25) 4.94 (1.41-15.76)
Non-Caucasian 205 (24.6) 17 (27.9) 7.16 (2.37-25.18) 2.31 (0.78-6.41)
Age (years)=y 26.065.14 24.1364.59 0.016 r = 0.041 0.216 r = 0.197 0.346
National Economic
Indicator (IEN)*||
0.956 0.836 0.552
1 (lowest) 304 (33.4) 24 (39.3) 8.16 (2.82-25.85) 4.94 (1.11-14.87)
2 (middle) 303 (33.3) 13 (21.3) 7.80 (2.67-28.34) 2.10 (0.86-18.10)
3 (highest) 302 (33.2) 24 (39.3) 9.29 (3.61-23.47) 2.38 (1.57-13.19)
Years of schooling=y 11.2263.51 10.9263.29 0.471 r = -0.042 0.210 r = 0.066 0.630
BMI=y 26.0465.42 24.6764.26 0.041 r = 0.268 p 0.001 r = 0.369 0.006
Abdominal circumference=y 85.78612.84 81.99612.18 0.020 r = 0.136 0.060 r = 0.129 0.012
Tobacco use*w 0.638 0.230 0.308
No 683 (75.6) 28 (46.7) 9.20 (3.28-25.72) 3.45 (1.72-11.90)
Yes 221 (24.4) 32 (53.3) 7.60 (2.40-27.41) 4.94 (0.74-22.41)
Alcohol use*w 0.002 0.006 0.048
No 811 (89.2) 45 (73.8) 9.15 (3.44-25.72) 4.11 (1.49-11.90)
Yes 100 (10.8) 16 (26.2) 3.49 (1.31-22.15) 2.33 (0.81-13.69)
Total 911 61 (6.7) 8.83 (3.01-25.72)
BMI = body mass index; IEN = Indicador Econoˆmico Nacional.
Leptin serum levels expressed by ng/mL.
* w2 test, presented as n (%);
wMann-Whitney test;
=Student’s t-test, presented as mean 6 standard deviation;
ySpearman’s or Pearson’s correlation test;
|| Kruskal-Wallis, both presented as median and interquartile range.
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CB1 cannabinoid receptor blockers, such as Rimonabant,
to produce weight loss and improve metabolic profile.16
However, the authors pointed out that smoking cannabis
does increase the risk of depression and anxiety, and
therefore, its use should be further investigated.
One possible explanation for our results is that the
number of women who reported smoking cannabis was
low, which may have caused the lack of significance in
leptin levels. Another possible explanation is that the
composition of the endogenous cannabinoid system is
distinct in women, with dynamic changes due to fluctua-
tions in gonadal sex hormones, as has been suggested in
preclinical studies.5 Unfortunately, in the present study,
we did not evaluate the influence of sex hormones or the
frequency or amount of cannabis smoked. Moreover, we
did not evaluate dietary habits. However, our study was able
to evaluate young subjects in a population-based study.
In the present study, we sought to evaluate the relation-
ship between cannabis use and changes in leptin levels.
Our results showed that cannabis smoking affects leptin
production, a hormone that inhibits hunger, as well as
that the response to biological signals can differ between
genders. Further studies are needed to investigate the
effects of THC on the endocannabinoid system and on
appetite hormones between genders.
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